149,988 members

Skip to content. | Skip to navigation

News

Groups hail Alzheimer's drug U-turn by health watchdog

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Groups hail Alzheimer's drug U-turn by health watchdog

Hundreds of thousands more patients in the early stages of Alzheimer's disease could get drug treatments following a U-turn by the health watchdog.

The National Institute for Health and Clinical Excellence, covering England and Wales, now says evidence backs the use of drugs for "mild" symptoms.

Current rules prevent NHS doctors prescribing donepezil, galantamine and rivastigmine in such early cases.

Campaigners said the release of the new draft guidance was a "momentous day".

As many as 465,000 people in the UK have Alzheimer's disease, and this is expected to rise as the population ages. More ….